Abstract Oxidative stress has been implicated in the pathogenesis of a number of diseases including Alzheimer's disease (AD). The oxidative stress hypothesis of AD pathogenesis, in part, is based on -amyloid peptide (A )-induced oxidative stress in both in vitro and in vivo studies. Oxidative modiWcation of the protein may induce structural changes in a protein that might lead to its functional impairment. A number of oxidatively modiWed brain proteins were identiWed using redox proteomics in AD, mild cognitive impairment (MCI) and A models of AD, which support a role of A in the alteration of a number of biochemical and cellular processes such as energy metabolism, protein degradation, synaptic function, neuritic growth, neurotransmission, cellular defense system, long term potentiation involved in formation of memory, etc. All the redox proteomics-identiWed brain proteins Wt well with the appearance of the three histopathological hallmarks of AD, i.e., synapse loss, amyloid plaque formation and neuroWbrillary tangle formation and suggest a direct or indirect association of the identiWed proteins with the pathological and/or biochemical alterations in AD. Further, A models of AD strongly support the notion that oxidative stress induced by A may be a driving force in AD pathogenesis.
Introduction
Oxidative stress has been implicated in the pathogenesis of a number of diseases including neurodegenerative disorders, cancer, ischemia, etc. [20] . Under physiological conditions, there is a balance between the pro-oxidant and anti-oxidant levels; however, certain environmental factors, stressors, or disease may cause an imbalance leading to increased production of reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS and RNS may react with biomolecules including proteins, lipids, carbohydrates, DNA and RNA [66] leading to oxidative damage of these biomolecules. Oxidative modiWcation of biomolecules has been shown to lead to cellular dysfunction [2, 24, 97, 101, 102, 148] . The markers of oxidative stress that are commonly studied to determine the level of oxidative stress in biological samples include protein carbonyls, 3-nitrotyrosine (3-NT), thiobarbituric acid reactive substance (TBARS), free fatty acid release, iso-and neuroprostane formation, acrolein and 4-hydroxy-2-nonenal (HNE), advanced glycation end products for carbohydrates, and 8-OH-2Ј-deoxyguanosine and 8-OH-guanosine and other oxidized bases, and altered DNA repair mechanisms [14, 20, 35, 48, 49, 96, 102, 138, 147, 154, 155, 159, 180] .
Protein carbonyls are formed by several diVerent mechanisms including free radical induced scission of the peptide backbone, oxidation of certain amino acid sides chain, HNE or acrolein covalent modiWcation of proteins [30] , and advanced glycation end products [102, 115] . Experimentally, levels of protein carbonyls are determined following derivatization of the carbonyl moiety by 2,4-dinitrophenylhydrazine that forms a hydrazone product which can be detected spectrophotometrically or immunochemically [30, 87, 158] . Further, protein oxidation also can be indexed by measuring the levels of 3-NT, a product formed by reaction of tyrosine with breakdown products of peroxynitrite. Peroxynitrite is formed by reaction of nitric oxide and superoxide, and is highly reactive with a half-life of less than 1 s. The levels of protein-bound 3-NT can be determined using immunochemical methods [73, 162] .
Lipid peroxidation is indexed by a number of markers including malondialdehyde (MDA), acrolein, and HNE [56, 107, 170] . The products of lipid peroxidation are highly reactive and can bind covalently to proteins by forming adducts with cysteine, lysine, or histidine residues [56] through Michael addition [30] . HNE accumulates in membranes at concentrations of 10 M to 5 mM in response to oxidative insults [56] and invokes a wide range of biological activities, including inhibition of protein and DNA synthesis [138, 170] , stimulation of phospholipases C and D [57] , disruption of Ca 2+ homeostasis, membrane damage, activation of stress signaling pathways and cell death [101, 165] . Since the cell membrane is rich in polyunsaturated fatty acid, increased levels of ROS can lead to increased production of toxic lipid peroxidation products, which can mediate oxidative stress-induced death in many cell types [164, 170] . Among all the body organs, brain is particularly vulnerable to oxidative damage because of high levels of polyunsaturated fatty acids in addition to its high oxygen consumption and high levels of redox transition metal ions and low levels of antioxidant enzymes. Previous studies have clearly documented increased levels of lipid peroxidation in neurodegenerative disease including AD [25, 113] .
Oxidation of proteins can lead to unfolding or conformational changes in the protein, thereby exposing more hydrophobic residues to an aqueous environment, which may lead to loss of structural or functional activity including aggregation and accumulation of oxidized proteins as cytoplasmic inclusions, as reported in AD [150] . Oxidatively modiWed proteins may have eVects on normal physiological processes by disrupting cellular functions such as alterations in protein expression and gene regulation, protein turnover, modulation of cell signaling, induction of apoptosis and necrosis, etc. [30] . In our laboratory, we used a redox proteomics approach to identify speciWc oxidatively modiWed brain proteins such as carbonylated, nitrated, HNE-bound, and glutathionylated brain proteins in neurodegenerative diseases including AD and models thereof [8, 9, 27, 32, 33, 35, 125, 132, 133, 155, 159] .
Role of Abeta in oxidative stress
Oxidative stress in AD brain Alzheimer's disease is histopathologically characterized by the presence of extracellular senile plaque (SP), predominantly consisting of Wbrillar amyloid-peptide (A ), intracellular neuroWbrillary tangles (NFTs), composed of hyperphosphorylated tau protein, and loss of synapses in the selected regions of the brain. However, the pathogenesis of AD largely remains unknown. Mutation of presenilin-1 (PS-1), presenilin-2 (PS-2), and APP genes has been reported to cause inherited AD [83, 153] . In addition, other genes like apolipoprotein E 4 (APOE) gene, endothelial nitric oxide synthase-3 gene, and the alpha-2-macroglobulin gene have been associated with AD [88] . Further, a number of hypotheses were proposed for AD mechanisms, which include: the amyloid cascade, excitotoxicity, oxidative stress, and inXammation hypothesis, and all of these hypotheses are based, to some extent, on the role of A [21, 68] .
Oxidative stress in AD brain is manifested by decreased levels of antioxidant enzymes and also by increased protein oxidation (including protein carbonyls and 3-NT formation), lipid peroxidation, DNA oxidation, advanced glycation end products, and ROS formation, among other indices [21, 85, 96, 102, 103] .
Oxidative stress in MCI brain
Mild cognitive impairment is considered as a boundary or transition stage between normal aging and dementia. MCI is characterized by loss of current memory without dementia or signiWcant impairment of other cognitive functions and with no loss of daily activities [114, 131] . Based on memory impairment, MCI is grouped into two broad groups, i.e., amnestic MCI and non-amnestic MCI. A large number of amnestic MCI subjects have been reported to convert to AD; however, there are cases where an amnestic MCI case has been reported to revert to normal stage. A number of MCI subjects show neuropathological hallmarks similar to AD, such as temporal lobe atrophy, while others showed low CSF-amyloid levels [38] . In addition, MCI also shows some genetic similarities to AD such as mutations in APOE4 [118, 136] .
In MCI patients, plasma levels of non-enzymatic antioxidants and activity of antioxidant enzymes appeared to be decreased when compared to those of controls [65, 140, 160] with no change in the levels of antioxidant protein levels [65] . Further, studies showed increased levels of oxidative damage in MCI indexed by elevated levels of markers such as 8-hydroxy-2-deoxy-guanosine (8-OhdG), 2,6-diamino-4-hydroxy-5-formamidopyrimidine (fapyguanine), 8-hydroxyadenine, 4,6-diamino-5-formamidopyrimidine (fapyadenine) and 5-hydroxycytosine, isoprostanes, HNE, protein carbonyls, 3-NT, etc. [27, 28, 36, 79, 95, 116, 163, 177] , which were indicative of oxidative stress in MCI [27, 29, 52, 79] and further supporting the notion that oxidative stress could be an early event in the progression of MCI to AD. Based on the oxidative stress and histopathological similarities, and also involvement of similar genes as risk factors for AD and MCI, studies of MCI may provide clues about AD pathogenesis, progression of AD, and to the development of therapeutics to treat or delay this dementing disorder.
A , a key player of oxidative stress A 40-42 amino acid peptide, A , is generated by proteolytic cleavage of amyloid precursor protein (APP), a transmembrane protein, by the action of beta-and gamma-secretases. Mutations in APP, presenilin-1 (PS-1) or presenilin-2 (PS-2) have been shown to lead to increased production of A and to early onset of AD [144] . Both A and were found in AD brain and a number of in vitro and in vivo studies showed that A (1-42), a primary component of SP, is more toxic than A (1-40) [8, 10, 11, 17, 111, 112] . In addition, small oligomers of A were suggested to be actual toxic species rather than Wbrillar A [51, 54, 84, 119, [171] [172] [173] . Many studies performed in our laboratory, focused attention on the neurotoxic mechanisms associated with increased levels of A (1-42), which is the major component of the senile plaques-one of the characteristic features of AD neuropathology. The amyloid -cascade hypothesis, suitably updated, postulates that A is likely central to the pathogenesis of AD [15, 68] . The mechanisms involved in A -mediated neurotoxicity are unknown, but there is evidence suggesting that oxidative stress plays a key role [14, 21, 68, 102] . Growing attention has focused on oxidative mechanisms of A toxicity as well as the search for novel neuroprotective agents. The ability of toxic Abeta peptides to induce protein oxidation and to inhibit the activity of oxidation-sensitive enzymes is consistent with the hypothesis that Abeta can induce severe oxidative damage. Research from our laboratory and others showed that among the 42 amino acids that were found in A , methionine located at position 35 is critical for A associated neurotoxicity [18, 41, 45, 75, 76, 117] . The assignment of the critical function to Met35 is based on its ability to undergo a 1-electron oxidation to form a sulfuranyl free radical, which can then undergo free radical chain reaction with allylic H-atoms on unsaturated acyl chains of lipids, thereby greatly increasing free-radical mediated lipid peroxidation and protein oxidation and providing a mechanism for formation of HNE. The substitution of Ile31 by proline, a helix breaking amino acid, i.e., A I31P, did not cause any protein oxidation or neurotoxicity in neuronal cell culture [76] ; this could be due to disruption of the interaction of the carboxyl oxygen of Pro31 with the S-atom of Met35. This interaction is proposed to facilitate the 1-electron oxidation of Met [18] . Studies conducted using computer modeling suggested that the -sheet conformation of this A peptide contains the sulfur-centered radical cation of Met35, which augment the generation of a -carbon centered radical on the Gly33 residue, which then leads to the formation of a hydrophobic environment that is ideal for lipid peroxidation in the lipid bilayer [13, 77] . Previous study from our laboratory showed that the presence of VitE blocks A induced neurotoxicity in neural cell culture, consistent with the notion that oxidative stress could be one of the key process in the progression of the AD pathogenesis [178] .
The amounts of A and SP were reported to be lower in MCI compared to AD [169] . In a model of AD, a direct correlation of the amount of A to oxidative stress was demonstrated [3] . Therefore, increased oxidative stress caused by A may lead to increased oxidative modiWcation of proteins and lipids, leading to impaired cellular function and cell death, and consequently to cognitive impartment and AD-like pathology. In this review, we have summarized our Wndings of the oxidatively modiWed protein in MCI, AD and animal models of AD to gain insight about the role of oxidative stress in the pathogenesis and progression of AD.
Redox proteomics
Redox proteomics techniques usually involve the coupling of two-dimensional (2D) gel electrophoresis techniques with mass spectrometry (MS) and 2D-Western blotting. This technique allows the identiWcation and quantiWcation of oxidatively modiWed proteins and is much advanced over traditional methods in that it allows for overall sample analysis for the detection of post-translational protein modiWcations such as protein carbonyls, protein-bound HNE, protein-resident 3-NT and glutathionylation, etc. [7, 48, 80, 81] . A detailed description of the applications and limitations of proteomics to the identiWcation of brain proteins is provided elsewhere [19, 27, 159] . BrieXy, some of the limitations of redox proteomics technique include solubilization of membrane proteins [142] , highly basic proteins, and inability to detect low-abundance proteins [19] . Use of charged detergents like sodium dodecyl sulfate (SDS) in isoelectric focusing (IEF) may lead to artifacts, which should be avoided. If necessary, neutral detergents like NP-40 should be used. Figure 1 shows an experimental scheme of the overall approach followed in our laboratory for the identiWcation of oxidatively modiWed proteins. In summary, brain samples are split into two equal aliquots and each separated by IEF followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The gel is stained with Sypro Ruby and scanned at the appropriate wavelengths for total protein detection; the proteins from a second gel are transferred to a nitrocellulose membrane for 2D Western blot analysis, followed by probing with antibodies of the post-translational modiWcation of interest and visualization with a colorimetric alkaline phosphatase detection system. Protein spots in gels and blots are aligned and matched utilizing PDQuest, a powerful image analysis software. Post-translational protein modiWcations of interest are calculated by normalization to total protein levels in the gel (i.e., the ratio of the spot intensity on the 2D blot to the spot intensity on the gel). This takes into account changes in protein levels that may inXuence the apparent post-translational protein modiWcation.
Oxidatively modiWed proteins in AD brain
Alzheimer's disease brain shows a regional diVerence in its pathology, and to large extent, AD-related pathology has been related to the amyloid load. For example, inferior parietal lobule and hippocampus have both high loads of amyloid and signiWcantly increased oxidative damage and loss of cells, whereas cerebellum showed low levels of -amyloid, no oxidative stress relative to controls, and essentially no neuronal loss [71, 155] . Our redox proteomics studies led to the identiWcation of oxidatively modiWed brain proteins, indexed by increased carbonyl levels, protein-bound HNE, 3-NT, and glutathionylation, and the identiWcation of these oxidatively modiWed proteins correlated with AD pathogenesis and strongly support a role of oxidative stress in AD pathogenesis. Using redox proteomics, we identiWed oxidatively modiWed proteins in the hippocampus (HP) and inferior parietal lobe (IPL) of the AD brain that are involved in diVerent cellular functions such as energy metabolism, protein degradation, cellular defense, etc. (Table 1) . 
Functional classiWcation of oxidatively modiWed brain proteins in AD
Energy dysfunction or mitochondrial alterations The energyrelated proteins, -enolase, triose phosphate isomerase (TPI), phosphoglycerate mutase 1 (PGM1), creatine kinase (CK), -enolase, lactate dehydrogenase (LDH), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), aconitase, aldolase, voltage dependent anion channel (VDAC), and ATP synthase, were identiWed to be oxidatively modiWed and dysfunctional in AD brain, and these proteins normally are involved directly or indirectly in cellular energy production and related cellular functions [32, 33, 35, 128, 155, 159, 161] . Most of the proteins, such as -enolase, TPI, PGM1, -enolase, LDH, GAPDH, and aldolase are related to the glycolytic pathway. This pathway is vitally important in the brain for energy production, since glucose is principle source of energy production in brain. The identiWcation of these proteins as oxidatively modiWed and dysfunctional proteins in AD brain suggests an impaired energy metabolism pathway leading to less production of ATP. Decreased production of ATP may lead to loss of synapses and synaptic function ultimately leading to memory loss, since ATP levels are extremely important at nerve terminals for normal neuronal connections. Further, decreased levels of ATP may also lead to alterations in ion motive ATPases and glucose and glutamate transporters cholinergic defects, disturbances in cholesterol homeostasis, altered protein synthesis, and signal transduction, etc., eventually leading to cell death and consequently to cognitive decline in Alzheimer's disease patients. Changes in cell potential, sequestration of Ca 2+ , and opening of voltage gated Ca 2+ channels all would be expected to be altered by decreased levels of ATP secondary to altered energy metabolism in the brain. In addition, altered ATP levels could lead to exposure of phosphatidylserine to the outer membrane leaXet, a signal for apoptosis [34, 110] . Our proteomic studies are consistent with previous studies of others using positron emission tomography (PET), who showed reduced levels of cerebral metabolic rate of glucose utilization in the AD brain regions that are severely aVected [174] . Further, VDAC and ATP synthase, related to mitochondria, were also found to be oxidatively modiWed [128, 161] . VDAC is a component of the mitochondrial permeability transition pore (MPTP), which plays an important role in importing and exporting various metabolites, including ATP, into the mitochondria. Being a part of MPTP, oxidation and functional impairment of this protein may lead to cell death via apoptosis pathways [100, 145] . Marin et al. showed that VDAC plays a role in A -mediated neurotoxicity [100] . Among all the energy related proteins that were identiWed to be oxidatively modiWed, enolase appears to be more susceptible to oxidative modiWcation, since it is the only protein that showed increased levels of protein carbonyls, enolase-bound HNE, and 3-NT in both hippocampus and IPL. However, it is not clear why enolase is more susceptible to all the three types of modiWcations [32, 33, 35, 128, 159, 161] . There are many diseases that are linked to enolase-dependent pathways, especially autoimmune and neurodegenerative disorders [122, 123] , and initial studies suggest enolase is oxidatively modiWed in brain from subjects with familial AD [22] .
Proteosomal dysfunction and synaptic dysfunction UCHL-1 is a member of ubiquitin-proteasome pathway and plays an important role in protein degradation, thereby preventing the aggregation of damaged proteins within the cell. The identiWcation of UCHL-1 as an oxidized and dysfunctional protein in AD brain [32, 39, 40, 159] suggests a dysfunctional ubiquitin-proteasome pathway and an increased accumulation of damaged and aggregated proteins and excess protein ubiquitinylation that may ultimately lead to synaptic degeneration in the AD brain [32, 78, 155] . Increased levels of protein aggregates have been reported in AD brain [78] . Further Gong et al. (2006) showed that the presence of UCHL-1 can recover synaptic function and contextual memory formation from A -induced oxidation [63] , indicating that UCH L-1 like enolase, may have more than one function. Taken together, oxidation of UCHL-1 may lead to altered protein degradation, synaptic function and memory in AD, and is consistent with known elevated ubiquitinylated proteins, proteosomal dysfunction, and protein accumulation in AD brain.
Neuritic abnormalities DRP-2, -actin, -tubulin were identiWed to be oxidatively modiWed proteins in AD brain [32, 35, 128, 155, 159] . These proteins are crucial for maintaining the structure of brain cells, neuronal repair and also for proper neuronal connections that play a key role in the learning and memory process. IdentiWcation of these proteins as oxidatively modiWed suggests a role of oxidative modiWcation in the loss of interneuronal connections, short dendritic length, impaired axonal transportation, and loss of structural integrity that might ultimately lead to neuronal death and AD-like pathology [6, 42, 149] . Further, DRP-2 has been reported to be down regulated in Down's syndrome and AD patients [99] .
Excitotoxicity Glutamate is an excitatory neurotransmitter that, after its release in the synaptic cleft and performance of its function, is taken up by glia cells via excitatory amino acid neurotransmitter transporter receptor (EAAT2), where Glu is converted to glutamine by glutamine synthethase (GS). Any impairment in the function of EAAT2 and GS may lead to increased levels of glutamate on the external surface of neurons, which may lead to over-stimulation of neurons, e.g., excitotoxicity and Ca 2+ entry leading to neuronal cell death [82] . Previous studies showed decreased activity of GS in AD brain [23, 71] . An in vitro study showed that A (1-42) can led to HNE modiWcation of EAAT2 [85] . The identiWcation of both EAAT2 (by immunochemical method [85] ) and GS (by proteomics) as oxidatively modiWed and dysfunctional proteins in AD brain is consistent with synaptic loss and neurodegeneration in AD [23, 32, 71, 128] .
Lipid abnormalities and cholinergic dysfunction Neuropolypeptide h3, also known as RAF kinase inhibitor (RKIP), phosphatidylethanolamine binding protein (PEBP), and hippocampal cholinergic neurostimulating protein (HCNP), is important for the production of choline acetyltransferase, an enzyme that play an important role in acetylcholine production, and also important in maintaining phospholipid asymmetry. Hence, decreased activity of this enzyme may lead to reduced levels of the neurotransmitter, acetylcholine, causing poor neurotransmission [120] . The oxidation and dysfunction of the neuropolypeptide h3 correlate well with the loss of cholinergic neurons in AD brain [44, 50, 129, 175] . Since neuropolypeptide h3 is also PEBP, it is possible that lipid asymmetry is also aVected by oxidized PEBP, and studies from our laboratory showed that lipid asymmetry is lost in synaptic membranes treated with A (1-42) or HNE [34, 110] . Both loss of lipid asymmetry and loss of cholinergic neurons have been reported in AD brain [5, 47, 61] .
pH buVering and CO 2 transport Carbonic anhydrase II (CAII) is an enzyme that catalyzes the hydration of CO 2 to HCO 3 ¡ and regulates the transport of CO 2 and HCO 3
¡
. The main function of CAII is maintenance of cellular pH, electrolytic and water balance [146] . Oxidative modiWcation and impairment of CAII function may lead to altered cellular pH that may lead to altered enzyme activities, and/or impairment of the mitochondrial proton gradient for ATP synthesis. In addition, altered pH may also lead to increased aggregation of proteins as seen in AD [106, 155] .
Cell cycle; tau phosphorylation; Abeta production Peptidyl-prolyl cis/trans isomerase 1 (Pin-1) regulates biological functions of proteins involved in protein assembly, folding, intracellular transport, intracellular signaling, transcription, cell cycle progression and apoptosis [26, 64, 98] . Pin1 regulates the function of both APP and tau proteins in addition to maintenance of cell cycle [67, 93, 98, 124] . Pin1 regulates the phosphorylation of tau protein via its action on both kinases and phosphatases [26, 181] . Studies showed that Pin1 could bind to APP and regulate the production of A [26, 124] . Hence, oxidation and reduced activity of Pin1 in AD brain will favor hyperphosphorylation of tau protein by dysregulation of kinases, such as GSK-3 , CDK5, etc., and by inhibiting the action of phosphatases, such as PP2A. Hyperphosphorylation of tau leads to neuroWbrillary tangle formation, which kills neurons [26, 72, 154, 159] . This notion is supported by the study that showed that Pin1 protects neurons against age-related neurodegeneration [93] . Further, Pin1 was reported to co-localize with phosphorylated tau in AD brain, and showed an inverse relationship to the levels of tau [72, 137] . Taken together, oxidation of Pin1 could be related to major pathological hallmarks of AD: senile plaques, neuroWbrillary tangles and synapse loss.
Synaptic abnormalities and LTP Intracellular membrane fusion and vesicular traYcking are important for the proper function of the synapse. These functions are regulated by soluble N-ethylmaleimide-sensitive factor (NSF) attachment proteins. NSF proteins regulate neurotransmitter release, hormone secretion, mitochondrial organization, and vesicular transport, and thereby play an important role in learning and memory. -Soluble NSF attachment protein ( -SNAP) is particularly involved in long-term potentiation, a process crucial for learning and memory [94] . IdentiWcation of -SNAP as one of the oxidized proteins in AD brain suggests impaired neurotransmission, and LTP learning and memory, and these alterations have a clear implications in AD symptoms [151, 155] .
Antioxidant defense/detoxiWcation system Manganese superoxide dismutase (MnSOD), glutathione S-transferase (GSTM3), multidrug resistant proteins 1 (MRP1), multidrug resistant proteins 3 (MRP3), and peroxiredoxin 6 (PR VI) are found as oxidatively modiWed in AD brain [128, 156] . Studies from our laboratory clearly showed that oxidation of most proteins lead to functional impairment, and this has been clearly documented in AD brain [27, 71, 85, 128, 133, 159, 161] . Since these proteins above are involved in cellular defense, loss of functional activity of antioxidant proteins may lead to increased levels of oxidants and consequently to oxidative stress that may lead to AD-like pathology and neuronal death. GST is a detoxiWcation enzyme that catalyses the conjugation of toxins (e.g., xenobiotics or HNE) with glutathione. The glutathioneconjugated toxic product is eZuxed out from the cell by MRP [139, 156, 166] . Hence, loss of GST and MRP1 or 3 protein function will lead to accumulation of the toxicant levels in the cell resulting in increased production of ROS and toxic products with subsequent oxidative stress and ultimately to cell death. Previous studies reported increased levels of HNE in AD brain that support the loss of function of MRP and GST protein and their role in AD pathogenesis [156] , consistent with proteomics identiWcation of brain resident MRP3.
Another protein found to be oxidatively modiWed includes mitochondrial resident peroxiredoxin VI (PR VI). This enzyme normally catalyzes the transformation of H 2 O 2 and the reduction of peroxynitrite. PR VI also is involved in detoxiWcation, cell diVerentiation and apoptosis [135] . Alterations in peroxiredoxin, consequently, would lead to increased nitration of proteins and decreased detoxiWcation eVects that are detrimental to brain [134] . Loss of MnSOD activity leads to increase in production of superoxide leading to increased levels of ROS and consequently to a build up of oxidative stress in mitochondria. Mitochondrial function is known to be compromised in AD brain.
Taken together, our redox proteomics approach has allowed us to identify a number of the proteins that are excessively oxidized in AD brain and shows a direct or indirect association of the identiWed proteins with the pathological and/or biochemical alterations in AD. Further, our Wndings strongly support the notion that oxidative stress does play a role in AD pathogenesis. However, it is not clear if increased A occurs before the onset of oxidative stress or the oxidative stress is the driving force for A production. Both processes are interrelated. Our laboratory has hypothesized that oxidative stress induced by A production is the driving force for neurodegeneration in AD and MCI (Fig. 2) . In order to better understand the relation between A and oxidative stress, we applied redox proteomics to identify oxidatively modiWed proteins in brain from subjects with MCI, arguably the earliest form of AD.
Oxidatively modiWed brain proteins in MCI and comparison to AD
A large number of proteins were found to be oxidatively modiWed in MCI brain compared to controls (Table 1) . These proteins were grouped based on their functional roles into various categories, such as energy dysfunction, neuritic abnormalities, excitotoxicity, lipid abnormalities and cholinergic dysfunction, pH buVering and CO 2 transport, cell cycle and APP and tau protein regulation, antioxidant, cell signaling and protein synthesis [27, 138, 163] . Comparing the functional categories between AD and MCI, we observed an overlap in dysfunction of energy-related proteins, neuritic abnormalities, excitotoxicity, lipid abnormalities and cholinergic dysfunction, pH buVering and CO 2 transport, cell cycle and APP and tau protein regulation, and antioxidant categories [27, 32, 33, 35, 128, 138, 159, 161, 163] . The appearance of oxidized brain proteins in common between AD and MCI suggests a possible involvement of critical pathways in the progression of MCI to AD (Fig. 3) . However, all the proteins that were identiWed to be oxidatively modiWed in AD brain were not found in brain from subjects with MCI, and conversely, there were some brain proteins that were detected as oxidatively modiWed in MCI but were not identiWed as excessively oxidized in AD brain. This result raises question as what makes a protein oxidized early in MCI but not detected later in AD? However, this issue is currently unanswered and requires further studies. In addition to the protein categories of MCI brain that are similar to those in AD brain, and are therefore discussed above, there are two main functional categories of proteins found to be oxidatively modiWed in MCI that were not found in AD, which include proteins involved in cell signaling and protein synthesis (Table 1 ). These two categories are discussed here [27, 138, 163] .
Two proteins, i.e., EF-Tu and eIF-, are involved in protein synthesis and were found to be oxidatively modiWed in MCI brain [138] . Oxidation and functional impairment of EF-Tu protein may lead to impaired protein synthesis in cells, especially in mitochondria, leading to loss of diVerentiation in diVerent cell types, energy impairment, and ultimately to cell death [90, 138] since EF-Tu aids protein translation in mitochondria, where it promotes protein chain elongation. eIF-binds on aminoacyl-tRNA acceptor sites of ribosomes in a GTP-dependent manner during protein synthesis [130] . In addition, to its role in protein synthesis, eIF-is reported to be involved in cytoskeletal organization, cell proliferation and senescence [168] . A number of studies have provided an indirect evidence of the impartment of brain protein synthesis in both AD and MCI [37, 53, 89] . Oxidation and impairment of eIF-and EF-Tu may contribute to this loss of brain protein synthesis in MCI and AD and may lead to loss of cell homeostasis leading to cell death [138] .
The second category of proteins in MCI brain discussed here includes cell signaling. One of the proteins that was identiWed to be oxidatively modiWed in MCI brain is 14-3-3 gamma, a member of the 14-3-3-protein family [138] . 14-3-3 proteins are involved in a number of cellular functions, including signal transduction, protein traYcking and metabolism. 14-3-3 gamma interacts with glycogen synthase kinase 3(GSK3 ), and tau, hence, likely plays a role in the regulation of tau phosphorylation. Consequently, it is tempting to speculate that oxidative modiWcation of this protein may lead to increased tangle formation in MCI and may contribute to progression of MCI to AD.
In vitro, ex vivo and in vivo model of Abeta
Animal models of Alzheimer's disease Animal models have been and continue to be important to understand the mechanisms of disease pathogenesis and progression and in developing therapeutic strategies for neurodegenerative diseases such as AD. Nevertheless, many animal models of AD do not closely resemble the pathology of human AD because they do not encompass all pathological features of AD, i.e., senile plaques and neuroWbrillary tangles, and some do not demonstrate neuronal loss. Thus, it is important to study diVerent animal models, each of which can provide important information to achieve a more comprehensive overview of the neurodegenerative mechanisms.
In this eVort, the studies performed in our laboratory employed both invertebrate (Caenorhabditis elegans) models that allow the use of powerful genetic and high-throughput screening methods, and mammalian models that more closely mimic human AD. These combined strategies are expected to enable researchers to gain a greater understanding of disease pathways and develop new approaches to drug discovery.
Neuronal cell cultures
Previous studies from our laboratory reported that primary neuronal cell cultures treated with A (1-42) showed increased production of reactive oxygen and nitrogen species (ROS/RNS), protein oxidation-as indexed by increased levels of carbonyls, HNE-bound proteins and formation of 3-NT-DNA and RNA oxidation and lipid peroxidation [12, 14-18, 20, 21, 25, 28] . Since protein oxidation has been shown to lead to conformational change in proteins, resulting in loss of protein function [152] , we aimed to identify the speciWc target of A -induced oxidative damage in neuronal cultures and to evaluate if this phenomenon could be prevented by pre-treatment with antioxidant compounds. For this purpose, we used proteomic techniques to identify neuronal proteins that were oxidized signiWcantly by A (1-42) treatment and also to test the protective eVect against protein oxidation of -glutamylcysteine ethyl ester (GCEE), which has been shown to upregulate intracellular levels of GSH, and the GSH mimetic, D609. We found that 14-3-3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were signiWcantly carbonylated. This Wnding is in agreement with results obtained on AD brain that reported dysfunction of both (Table 2) [35, 143, 161] . Interestingly, GCEE-induced upregulation of GSH or D609 protect both the proteins against oxidation after exposure to A (1-42) [9, 12, 75, 157, 158 ].
14-3-3 protein is involved in kinase activation and chaperone activity, among other functions related to signaling pathways, in addition to key roles in cell cycle regulation and development [58] . As noted above, previous immunohistochemical studies have shown that 14-3-3 colocalizes with phospho-tau in NFTs in AD [86] and stimulates tau phosphorylation [141] . Interestingly, 14-3-3 was found to be a target of oxidative damage in AD human cortex as a result of A -induced oxidative stress [143] . As previously shown in our laboratory, GAPDH was found to be oxidatively modiWed with decreased enzyme activity in AD brain [163] , a Wnding replicated in AD Wbroblasts [105] .
Thus, our Wndings of increased oxidation of GAPDH and 14-3-3 in neuronal cell cultures treated with A (1-42) demonstrated the central role played by this peptide which, also in vitro models of AD, lead to selective protein oxidation that closely resemble human pathology. In addition, since A (1-42) is a mediator of oxidative stress, antioxidant therapies, such as upregulation of GSH or use of a GSH mimetic, may potentially be eVective in slowing or ameliorating the neurodegenerative process as shown by protection of GAPDH and 14-3-3 from increased levels of oxidation induced by A (1-42).
Synaptosomal system
Loss of synaptic terminals in AD brain demonstrates a higher correlation with decreased cognitive function than do cell death or plaque development that has led to the hypothesis that disappearance of synapses is a key event in early cognitive decline [104, 167] . The cellular location of initial amyloid-related damage is controversial, but a growing body of evidence suggests that intracellular accumulation of A precedes plaque formation. However, the mechanisms of synapse loss in AD remain uncertain. Nevertheless, the damage in these regions is directly correlated with severity of dementia, oxidative stress, and deposition of A (1-42) . Therefore, the investigation of oxidative damage occurring in synaptosomes isolated from rodent brain has been shown to be a suitable experimental model to study the extent of A -induced toxicity [85, 104] . Incubation of isolated synaptosomes with A (1-42) leads to protein oxidation [14, 74, 126] ; hence, we used a redox proteomic approach to identify proteins that are speciWc targets of oxidative damage induced by A (1-42) .
Our results contributed insights into the mechanisms leading to the synaptic alterations found in AD brain. As described above, we utilized two-dimensional gel electrophoresis, immunochemical detection of protein carbonyls, and mass spectrometry to identify proteins from synaptosomes isolated from Mongolian gerbils. A (1-42) treatment leads to oxidative modiWcation of -actin, glial Wbrillary acidic protein, dihydropyrimidinase-related protein-2, H + -transporting two-sector ATPase, syntaxin binding protein 1, glutamate dehydrogenase, -actin, and elongation factor Tu as indexed by increased carbonyl levels ( Table 2 ). The listed proteins are involved in a wide variety of cellular functions including neuronal network formation and transmission, energy metabolism, excitotoxicity, protein synthesis, and cytoskeletal integrity. According to our previous Wndings in human samples [28] or animal models of AD [16] , we suggest that oxidation and subsequent loss of function of the proteins identiWed would lead to excitotoxicity, the disruption of the synapse and neuronal communication, and inhibition of protein synthesis as shown in Tables 1 and 2 . Further, similar proteins were identiWed by proteomics and in AD and/or MCI brain to be oxidatively damaged. This experimental model provides a useful tool to establish a direct link between Abeta toxicity and synapse loss, consistent with the clinical impairment observed in AD subjects.
Intracerebral injection of A (1-42) model (in vivo model)
Cholinergic hypofunction contributes to dementia-related cognitive decline and remains a target of therapeutic intervention for Alzheimer's disease. The cholinergic hypothesis suggests that a dysfunction of acetylcholine-containing neurons in the basal forebrain contributes substantially to the cognitive decline observed in senescent and AD subjects [62, 176] . Many therapeutic strategies and drug development approaches for AD to date have been designed to prevent or attenuate the cholinergic dysfunction. However, disappointing clinical results have been reported with some muscarinic agonists in patients with Alzheimer's disease [59] . A cholinergic hypofunction in Alzheimer's disease can be linked to the formation of neurotoxic A , which can further decrease the release of acetylcholine (a presynaptic eVect) and impair the coupling of muscarinic receptors with G-proteins (a postsynaptic eVect) [60] . This uncoupling leads to decreased signal transduction, impairments in cognition, a reduction in the levels of trophic-secreted amyloid precursor proteins, the generation of more neurotoxic -amyloids and a further decrease in acetylcholine release. This 'vicious cycle' may be prevented, in principle, by M-selective agonists [60] .
In order to investigate the impact of cholinergic dysfunction on AD neuropathology and clinical symptoms, a cholinergic animal model of AD was prepared by injecting into the nucleus basalis of the rat pre-aggregated A (1-42). We and others have measured in this animal model, the levels of oxidative stress in diVerent brain regions-hippocampus, Table 2 Redox proteomics identiWcation of oxidatively modiWed proteins in animal models of AD Energy-, excitotoxic-, neurotransmission-, and structure-related cortex and nucleus basalis-and we found that hippocampus showed the highest level of oxidative damage-measured as the extent of protein oxidation-compared to that of other aVected regions [11, 62] . In order to better understand the speciWc targets of oxidative damage, we used proteomic techniques to identify proteins that are speciWcally oxidized in diVerent regions of rat brain injected with A (1-42) into the nucleus basalis magnocellularis (NBM) compared with saline-injected control, 7 days post-injection. In the NBM, we found 14-3-3 and chaperonin 60 to be signiWcantly oxidized, while in the cortex, we identiWed GS and a mixture of tubulin chain 15 and -tubulin to be signiWcantly oxidatively modiWed (Table 2 ). Finally, in the hippocampus, we identiWed -synuclein, 14-3-3 , GAPDH, pyruvate dehydrogenase, and PGM1 as speciWc targets of A (1-42)-induced protein oxidation ( Table 2) . We further conWrmed that oxidized proteins are involved in several cellular functions, including synaptic function and structure ( -synuclein), signal transduction (14-3-3 ), energy metabolism (PGM1, pyruvate dehydrogenase, and GAPDH), and stress responses (HSP60) [11] . Interestingly, a number of proteins that were identiWed in this animal model were already reported to be oxidatively modiWed in AD brain, including PGM1, GAPDH, GS, 14-3-3 and tubulin [32, 35, 161] . These results showed not only selective protein damage in the NBM around the injection site, but also in other brain regions including the cortex and hippocampus. Moreover, dysfunction of these oxidatively modiWed proteins leads to excitotoxicty, oxidative stress, protein aggregation and cholinergic hypofunction all of which are characteristic pathological hallmarks of AD. In addition, these proteins have been identiWed to be oxidatively modiWed in AD brain [28, 32, 35, 163] and demonstrate the importance of ex vivo models of A (1-42)-induced neurotoxicity.
Human A (1-42)-expressing C. elegans
Transgenic C. elegans nematodes have been engineered to express potentially amyloidic human proteins. In this worm model, human A (1-42) is expressed through a body-wall muscle myosin promoter and an A minigene [92] in an attempt to generate signiWcant extracellular levels of amyloid beta-peptide. This system mimics to some extent the situation postulated to exist in the human brain and might provide insights into A -mediated neurotoxicity.
In our laboratory, we used this invertebrate model to gain insight into the toxic mechanisms associated to the oligomerization and deposition of Abeta which is considered to play a central role in AD pathogenesis. Consistent with this notion, we measured increased levels of protein oxidation in C. elegans expressing human A (1-42). Substitution of the codon of the single Met residue of human A (1-42) also suggested the involvement of methionine 35 of A in the mechanisms leading to increased levels of oxidative damage [179] . By using redox proteomics, we were able to identify which speciWc proteins underwent signiWcant oxidative modiWcations thus leading to their dysfunction. C. elegans-containing Abeta, expressed for a speciWc period of time, showed 16 proteins that were oxidatively modiWed when compared to controls. These proteins included: ATP synthase chain, glutamate dehydrogenase, proteasome -and -subunit, glutathione S-transferase ( -class), medium and short-chain acyl-CoA dehydrogenase, arginine kinase, myosin regulatory light chain, actin, adenosine kinase, malate dehydrogenase, transketolase, translation elongation factor EF-1 , lipid binding protein, and RACK1 ortholog ( Table 2 ). The impact of these results are multiple, since these identiWed proteins are involved in a variety of cellular functions including energy metabolism, protein degradation, cytoskeletal integrity, antioxidant system, signal transduction, and lipid metabolism. It is important to underline that many of these oxidized proteins, and their functional class also were found to be impaired in AD brain as described above.
Invertebrate models of neurodegenerative diseases, such as the C. elegans AD model, proved to be a viable approach for investigating the molecular processes underlying these diseases [91] . Parallel studies in diVerent animal models and human samples support the relevance of this model and further conWrm the pivotal role played by A accumulation as one of the leading causes of AD neuropathology. However, the usefulness of the various invertebrate models of neurodegenerative diseases currently being studied will be further demonstrated with the identiWcation of gene expression changes that can precede or overlap the A toxic cascade.
Canine model
One of the characteristic features that correlates canine aging with human aging is the neuropathology associated with -amyloid that naturally accumulates with age and is identical to human A [46, 70] . In particular, aged beagles have the identical amino acid sequence of A (1-42) as humans, and A plaques form in aged beagle brain. Consequently, aged dogs can be used to study the events involved with the production and accumulation of A without the introduction of genetic mutations that overexpress abnormal proteins. Plaques accumulate with a similar distribution and contain similar species of A in dogs as in humans and thus, the proteins involved with A production and eVects are hypothesized as a common feature in dog and humans. In addition, dogs accumulate the longer, more toxic form of A prior to the deposition of the shorter, more soluble A (1-40) in an age-dependent manner, which is consistent with human brain aging. Consistent with this neuropathologic feature, canines exhibit an age-dependent increase in protein carbonyl formation in brain [121] and similar results have been reported for aged rodents, humans, and also for subjects with AD [31, 71] . In addition, canine models absorb dietary nutrients in similar ways as humans, and therefore they can be used to test the protective role of antioxidant compounds against increased oxidative damage occurring in brain aging. Accordingly, previous studies performed in aged canines showed that long-term antioxidant administration reduces cognitive decline [69, 108] and leads to rapid improvements in complex learning ability in aging dogs [43, 109] .
In order to evaluate the protective eVects of an antioxidant-supplemented diet combined with behavioral enrichment (to enhance synapse formation), we used redox proteomics to identify brain proteins that showed decreased oxidation in aged beagles compared to control aged animals [121] . By following this approach, we were able to identify speciWc proteins that were protected from oxidative modiWcation in aged beagles. These proteins were glutamate dehydrogenase (GDH), GAPDH, -enolase, neuroWlament triplet L protein, GST and fascin actin bundling protein (Table 2 ) [121] . These proteins are involved in energy metabolic pathways, maintenance and stabilization of cell structure and participate in cellular defense mechanisms.
At the same time, we were interested to see if the decreased oxidative damage also could be associated with the induction of protective enzymes. Interestingly, we observed an increased activity of key antioxidant enzymes such as glutathione-S-transferase (GST) and superoxide dismutase (SOD) in co-treated animals compared to controls. We suggest that the induction of these protective proteins contribute to the prevention of protein oxidative modiWcation and their resultant dysfunction. Accordingly, protection of these speciWc proteins from oxidative modiWcations in aged beagles that received antioxidant supplementation resulted in an improvement of learning and memory [121] .
The suitability of this animal model is further conWrmed by the Wndings that enolase, GAPDH and GST were oxidized both in AD subjects and in aged beagle dogs. These results are consistent with a central role of Abeta-induced oxidative damage and oVer a powerful model to test novel therapeutic approaches designed to delay the onset of AD pathology. We propose that pharmacological strategies should combine diVerent approaches, such as behavioral enrichment with an antioxidant supplementation, since synergistic eVects could result from these kind of approaches.
Future research
Redox proteomics is an emerging technique that allows the identiWcation of oxidatively modiWed proteins in neurodegenerative diseases such as AD. Protein oxidation results from increased oxidative stress, which is considered to be crucially involved in the pathogenesis of several neurodegenerative disorders. Many studies have demonstrated the central role played by A as a potent inducer or ROS production, as also shown by in vitro and in vivo animal models of AD. A dual relation exists between A and the production of free radicals. Not only can the oxidative processes transform non-aggregated A into aggregated A in vitro [55] , but also A itself is a source of free radicals. Indeed, among the large array of pathological abnormalities seen in the AD brain, it seems increasingly likely that brain amyloidosis is the driving force underlying the involvement of oxidative stress in neurodegeneration and clinical impairments characteristic of AD. Further, the identiWcation of a large number of oxidatively modiWed proteins in common among MCI, AD and AD animal models suggests that A plays an important in AD pathogenesis (Table 3) .
Extensive oxidative damage observed in MCI brain regions [27] [28] [29] 79] suggest that oxidative stress may be an early event in the progression from normal brain to AD pathology. Based on these notions, it seems likely that increased production of ROS may act as important mediator of synaptic loss and eventually promote neuroWbrillary tangles and senile plaque deposition [27, 35, 155, 156, 161] . Studies performed on MCI samples will enable researchers to better understand the mechanisms leading to AD by identifying early markers of the disease. Such information may be useful for developing therapeutic strategies with the hope that early treatment will slow or prevent the progression of AD. For this purpose, our laboratory is currently testing novel therapeutic approaches aimed to inhibit oxidative damage in MCI, AD, and models thereof [1, 4, 11, 28, 75, 127, 162] . We suggest that the use of novel, 
